X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-04-01 | RXST | Rxsight, Inc. | Thunen Shelley B | CFO | S - Sale | $49.90 | -20,000 | 22,093 | -48% | -$997,946 | ||||||
| D | 2024-03-18 | COO | Cooper Companies, Inc. | Ricupati Agostino | SVP, CAO | S - Sale+OE | $100.89 | -54,724 | 5,081 | -92% | -$5,521,230 | |||||
2024-03-14 | STAA | Staar Surgical Co | Weisner Aimee S | Dir | P - Purchase | $38.11 | +1,750 | 10,864 | +19% | +$66,693 | ||||||
2024-03-11 | WRBY | Warby Parker Inc. | Miller Steven Clive | CFO | S - Sale | $11.98 | -24,225 | 166,879 | -13% | -$290,216 | ||||||
| DM | 2024-03-07 | COO | Cooper Companies, Inc. | Weiss Robert S | Dir | S - Sale+OE | $102.20 | -241,288 | 578,132 | -29% | -$24,659,342 | |||||
| DM | 2024-03-06 | WRBY | Warby Parker Inc. | Gilboa David Abraham | Co-CEO | S - Sale+OE | $12.09 | -80,376 | 12,306 | -87% | -$971,528 | |||||
| D | 2024-03-06 | WRBY | Warby Parker Inc. | Miller Steven Clive | CFO | S - Sale+OE | $11.88 | -8,708 | 191,104 | -4% | -$103,451 | |||||
| DM | 2024-03-06 | WRBY | Warby Parker Inc. | Blumenthal Neil Harris | Co-CEO | S - Sale+OE | $12.21 | -78,311 | 412,177 | -16% | -$956,335 | |||||
2024-03-05 | COO | Cooper Companies, Inc. | Petersmeyer Gary S | Dir | S - Sale | $103.51 | -1,000 | 9,056 | -10% | -$103,506 | ||||||
2024-03-05 | WRBY | Warby Parker Inc. | Miller Steven Clive | CFO | S - Sale | $12.12 | -8,963 | 178,653 | -5% | -$108,632 | ||||||
2024-03-05 | WRBY | Warby Parker Inc. | Gilboa David Abraham | Co-CEO | S - Sale | $12.12 | -16,731 | 12,306 | -58% | -$202,780 | ||||||
2024-03-05 | WRBY | Warby Parker Inc. | Blumenthal Neil Harris | Co-CEO | S - Sale | $12.12 | -16,731 | 412,177 | -4% | -$202,780 | ||||||
| D | 2024-03-01 | RXST | Rxsight, Inc. | Thunen Shelley B | CFO | S - Sale+OE | $56.37 | -10,000 | 42,093 | -19% | -$563,726 | |||||
| DM | 2024-02-14 | RXST | Rxsight, Inc. | Goldshleger Ilya | COO | S - Sale+OE | $54.00 | -25,000 | 27,847 | -47% | -$1,350,000 | |||||
| M | 2024-02-12 | RXST | Rxsight, Inc. | Tammenoms Bakker Juliet | Dir | P - Purchase | $50.83 | +8,000 | 31,388 | +34% | +$406,673 | |||||
| D | 2024-02-09 | RXST | Rxsight, Inc. | Goldshleger Ilya | COO | S - Sale+OE | $50.74 | -10,365 | 27,847 | -27% | -$525,939 | |||||
| DM | 2024-02-05 | RXST | Rxsight, Inc. | Thunen Shelley B | CFO | S - Sale+OE | $47.31 | -25,000 | 55,784 | -31% | -$1,182,660 | |||||
2024-02-01 | RXST | Rxsight, Inc. | Link William J Phd | Dir | S - Sale | $49.67 | -28,250 | 45,797 | -38% | -$1,403,120 | ||||||
| D | 2024-02-01 | RXST | Rxsight, Inc. | Goldshleger Ilya | COO | S - Sale+OE | $49.29 | -7,129 | 27,847 | -20% | -$351,411 | |||||
2024-02-01 | RXST | Rxsight, Inc. | Weinberg Eric | Chief Commercial Officer | S - Sale | $50.00 | -10,000 | 307,131 | -3% | -$500,004 | ||||||
| D | 2024-01-26 | RXST | Rxsight, Inc. | Thunen Shelley B | CFO | S - Sale+OE | $47.11 | -31,772 | 35,193 | -47% | -$1,496,706 | |||||
2024-01-22 | RXST | Rxsight, Inc. | Weinberg Eric | Chief Commercial Officer | S - Sale | $48.00 | -10,000 | 317,131 | -3% | -$480,006 | ||||||
| D | 2024-01-22 | RXST | Rxsight, Inc. | Goldshleger Ilya | COO | S - Sale+OE | $48.00 | -5,000 | 27,847 | -15% | -$240,000 | |||||
2024-01-18 | RXST | Rxsight, Inc. | Maniar Shweta | Dir | S - Sale | $45.72 | -6,399 | 12,130 | -35% | -$292,555 | ||||||
2024-01-08 | STAA | Staar Surgical Co | Broadwood Partners, L.P. | 10% | P - Purchase | $27.11 | +4,042 | 21,562,760 | 0% | +$109,570 | ||||||
| D | 2024-01-09 | RXST | Rxsight, Inc. | Goldshleger Ilya | COO | S - Sale+OE | $47.00 | -5,000 | 27,847 | -15% | -$235,000 | |||||
2024-01-09 | RXST | Rxsight, Inc. | Weinberg Eric | Chief Commercial Officer | S - Sale | $46.00 | -10,000 | 327,131 | -3% | -$460,000 | ||||||
2024-01-08 | RXST | Rxsight, Inc. | Weinberg Eric | Chief Commercial Officer | S - Sale | $42.00 | -10,000 | 337,131 | -3% | -$420,000 | ||||||
2024-01-08 | RXST | Rxsight, Inc. | Warner Robert Keith | Dir | S - Sale | $42.69 | -23,750 | 27,733 | -46% | -$1,013,894 | ||||||
2024-01-08 | RXST | Rxsight, Inc. | Maniar Shweta | Dir | S - Sale | $45.00 | -6,418 | 18,529 | -26% | -$288,810 | ||||||
2024-01-08 | RXST | Rxsight, Inc. | Kurtz Ronald M Md | Pres, CEO | S - Sale | $44.25 | -62,500 | 844,610 | -7% | -$2,765,631 | ||||||
| D | 2024-01-08 | RXST | Rxsight, Inc. | Goldshleger Ilya | COO | S - Sale+OE | $43.33 | -15,000 | 27,850 | -35% | -$650,000 | |||||
2024-01-08 | RXST | Rxsight, Inc. | Corley Jesse Anderson | Dir | S - Sale | $45.03 | -2,000 | 513,340 | 0% | -$90,059 | ||||||
| M | 2024-01-03 | STAA | Staar Surgical Co | Broadwood Partners, L.P. | 10% | P - Purchase | $28.61 | +226,553 | 21,554,676 | +1% | +$6,481,557 | |||||
2024-01-04 | COO | Cooper Companies, Inc. | Petersmeyer Gary S | Dir | S - Sale | $336.03 | -150 | 4,961 | -3% | -$50,404 | ||||||
| D | 2024-01-02 | RXST | Rxsight, Inc. | Thunen Shelley B | CFO | S - Sale+OE | $39.24 | -10,000 | 30,693 | -25% | -$392,409 | |||||
2023-12-27 | RXST | Rxsight, Inc. | Kurtz Ronald M Md | Pres, CEO | S - Sale | $41.09 | -22,500 | 907,110 | -2% | -$924,498 | ||||||
2023-12-22 | RXST | Rxsight, Inc. | Weinberg Eric | Chief Commercial Officer | S - Sale | $40.00 | -1,285 | 347,131 | 0% | -$51,400 | ||||||
| D | 2023-12-22 | RXST | Rxsight, Inc. | Goldshleger Ilya | COO | S - Sale+OE | $40.00 | -5,000 | 27,847 | -15% | -$200,000 | |||||
| D | 2023-12-19 | COO | Cooper Companies, Inc. | Weiss Robert S | Dir | S - Sale+OE | $364.81 | -79,370 | 215,226 | -27% | -$28,955,135 | |||||
| D | 2023-12-18 | RXST | Rxsight, Inc. | Goldshleger Ilya | COO | S - Sale+OE | $39.02 | -10,937 | 27,847 | -28% | -$426,710 | |||||
2023-12-15 | RXST | Rxsight, Inc. | Weinberg Eric | Chief Commercial Officer | S - Sale | $40.01 | -8,715 | 348,416 | -2% | -$348,711 | ||||||
| D | 2023-12-15 | RXST | Rxsight, Inc. | Thunen Shelley B | CFO | S - Sale+OE | $39.33 | -40,000 | 30,693 | -57% | -$1,573,310 | |||||
2023-12-14 | RXST | Rxsight, Inc. | Corley Jesse Anderson | Dir | S - Sale | $40.12 | -12,000 | 515,340 | -2% | -$481,469 | ||||||
2023-12-14 | RXST | Rxsight, Inc. | Kurtz Ronald M Md | Pres, CEO | S - Sale | $39.70 | -40,000 | 929,610 | -4% | -$1,588,186 | ||||||
2023-12-14 | WRBY | Warby Parker Inc. | Miller Steven Clive | CFO | S - Sale | $12.22 | -10,875 | 166,879 | -6% | -$132,893 | ||||||
2023-12-14 | COO | Cooper Companies, Inc. | Petersmeyer Gary S | Dir | S - Sale | $368.55 | -300 | 2,664 | -10% | -$110,565 | ||||||
| M | 2023-12-08 | RXST | Rxsight, Inc. | Warner Robert Keith | Dir | S - Sale | $35.03 | -20,000 | 51,483 | -28% | -$700,551 | |||||
| D | 2023-12-08 | WRBY | Warby Parker Inc. | Blumenthal Neil Harris | Co-CEO | S - Sale+OE | $10.56 | -56,038 | 400,106 | -12% | -$591,761 | |||||
| D | 2023-12-08 | WRBY | Warby Parker Inc. | Gilboa David Abraham | Co-Chief Exec Office | S - Sale+OE | $10.56 | -56,038 | 235 | -100% | -$591,761 | |||||
| DM | 2023-12-08 | WRBY | Warby Parker Inc. | Miller Steven Clive | CFO | S - Sale+OE | $11.19 | -29,310 | 177,754 | -14% | -$328,047 | |||||
2023-12-06 | STAA | Staar Surgical Co | Zhou Lilian Yansheng | Dir | P - Purchase | $30.74 | +850 | 2,327 | +58% | +$26,129 | ||||||
| M | 2023-11-28 | RXST | Rxsight, Inc. | Tammenoms Bakker Juliet | Dir | S - Sale | $29.73 | -494,313 | 23,388 | -95% | -$14,695,695 | |||||
| M | 2023-11-28 | STAA | Staar Surgical Co | Broadwood Partners, L.P. | 10% | P - Purchase | $31.50 | +434,991 | 21,101,570 | +2% | +$13,703,831 | |||||
| M | 2023-11-14 | RXST | Rxsight, Inc. | Tammenoms Bakker Juliet | Dir | S - Sale | $27.18 | -500,000 | 960,791 | -34% | -$13,590,750 | |||||
| M | 2023-11-10 | STAA | Staar Surgical Co | Broadwood Partners, L.P. | 10% | P - Purchase | $32.74 | +34,827 | 20,231,588 | 0% | +$1,140,132 | |||||
| M | 2023-11-07 | STAA | Staar Surgical Co | Broadwood Partners, L.P. | 10% | P - Purchase | $33.42 | +289,140 | 20,161,934 | +1% | +$9,662,782 | |||||
| M | 2023-11-02 | STAA | Staar Surgical Co | Broadwood Partners, L.P. | 10% | P - Purchase | $34.93 | +309,154 | 19,583,654 | +2% | +$10,797,514 | |||||
| M | 2023-10-04 | STAA | Staar Surgical Co | Broadwood Partners, L.P. | 10% | P - Purchase | $37.81 | +205,296 | 18,965,346 | +1% | +$7,762,466 | |||||
2023-09-21 | STAA | Staar Surgical Co | Lin Elizabeth Yeu | Dir | P - Purchase | $40.00 | +2,500 | 2,855 | +704% | +$100,000 | ||||||
| M | 2023-09-19 | STAA | Staar Surgical Co | Broadwood Partners, L.P. | 10% | P - Purchase | $40.12 | +291,383 | 18,554,754 | +2% | +$11,689,354 | |||||
| D | 2023-09-08 | WRBY | Warby Parker Inc. | Blumenthal Neil Harris | Co-CEO | S - Sale+OE | $11.92 | -5,016 | 400,106 | -1% | -$59,791 | |||||
| D | 2023-09-08 | WRBY | Warby Parker Inc. | Miller Steven Clive | CFO | S - Sale+OE | $11.92 | -7,607 | 187,252 | -4% | -$90,675 | |||||
| D | 2023-09-08 | WRBY | Warby Parker Inc. | Gilboa David Abraham | Co-CEO | S - Sale+OE | $11.92 | -5,016 | 235 | -96% | -$59,791 | |||||
| M | 2023-09-07 | RXST | Rxsight, Inc. | Tammenoms Bakker Juliet | Dir | S - Sale | $30.14 | -32,950 | 1,460,791 | -2% | -$992,969 | |||||
| M | 2023-09-05 | STAA | Staar Surgical Co | Broadwood Partners, L.P. | 10% | P - Purchase | $41.42 | +189,962 | 17,971,988 | +1% | +$7,868,913 | |||||
2023-08-29 | RXST | Rxsight, Inc. | Maniar Shweta | Dir | S - Sale | $28.06 | -4,292 | 24,947 | -15% | -$120,451 | ||||||
2023-08-25 | RXST | Rxsight, Inc. | Tammenoms Bakker Juliet | Dir | S - Sale | $29.25 | -16,208 | 1,048,341 | -2% | -$474,129 | ||||||
2023-08-21 | WRBY | Warby Parker Inc. | Durable Capital Partners LP | 10% | S - Sale | $12.23 | -402,535 | 9,690,563 | -4% | -$4,923,003 | ||||||
| M | 2023-08-17 | RXST | Rxsight, Inc. | Tammenoms Bakker Juliet | Dir | S - Sale | $29.62 | -33,135 | 1,775,863 | -2% | -$981,570 | |||||
2023-08-14 | WRBY | Warby Parker Inc. | Briggs Teresa | Dir | S - Sale | $12.94 | -9,720 | 45,282 | -18% | -$125,788 | ||||||
2023-08-07 | STAA | Staar Surgical Co | Weisner Aimee S | Dir | P - Purchase | $48.72 | +2,000 | 5,417 | +59% | +$97,440 | ||||||
2023-06-22 | WRBY | Warby Parker Inc. | Durable Capital Partners LP | 10% | S - Sale | $11.91 | -24,151 | 10,093,098 | 0% | -$287,638 | ||||||
| M | 2023-06-20 | WRBY | Warby Parker Inc. | Durable Capital Partners LP | 10% | S - Sale | $11.91 | -220,610 | 10,117,249 | -2% | -$2,627,117 | |||||
| M | 2023-06-15 | WRBY | Warby Parker Inc. | Durable Capital Partners LP | 10% | S - Sale | $11.94 | -88,237 | 10,337,859 | -1% | -$1,053,384 | |||||
| M | 2023-06-13 | WRBY | Warby Parker Inc. | Durable Capital Partners LP | 10% | S - Sale | $12.03 | -175,364 | 10,426,096 | -2% | -$2,109,242 | |||||
| M | 2023-06-08 | WRBY | Warby Parker Inc. | Durable Capital Partners LP | 10% | S - Sale | $12.02 | -57,028 | 10,601,460 | -1% | -$685,259 | |||||
| D | 2023-06-09 | WRBY | Warby Parker Inc. | Miller Steven Clive | CFO | S - Sale+OE | $11.69 | -7,652 | 176,377 | -4% | -$89,452 | |||||
| D | 2023-06-09 | WRBY | Warby Parker Inc. | Gilboa David Abraham | Co-CEO | S - Sale+OE | $11.69 | -5,043 | 235 | -96% | -$58,953 | |||||
| D | 2023-06-09 | WRBY | Warby Parker Inc. | Blumenthal Neil Harris | Co-CEO | S - Sale+OE | $11.69 | -5,043 | 400,106 | -1% | -$58,953 | |||||
| M | 2023-06-06 | WRBY | Warby Parker Inc. | Durable Capital Partners LP | 10% | S - Sale | $12.11 | -377,421 | 10,658,488 | -3% | -$4,572,393 | |||||
| M | 2023-05-22 | EYE | National Vision Holdings, Inc. | Peeler D Randolph | Dir | P - Purchase | $25.65 | +40,470 | 191,747 | +27% | +$1,038,093 | |||||
2023-05-17 | EYE | National Vision Holdings, Inc. | Taylor Thomas V | Dir | P - Purchase | $24.04 | +2,079 | 25,556 | +9% | +$49,979 | ||||||
2023-05-15 | EYE | National Vision Holdings, Inc. | Fahs L Reade | CEO | P - Purchase | $23.81 | +12,625 | 919,980 | +1% | +$300,601 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |